Document is current
Any future updates will be listed below
-
Authors
Iannone, Valeria https://orcid.org/0000-0003-2114-1366
Vaittinen, Maija
Gómez-Gallego, Carlos https://orcid.org/0000-0003-0219-1827
Mikkonen, Santtu https://orcid.org/0000-0003-0595-0657
Lok, Johnson
D’Auria, Giuseppe
Vazquez-Uribe, Ruben https://orcid.org/0000-0002-9800-0409
Tikkanen, Ida
Sommer, Morten Otto Alexander
El-Nezami, Hani
Kolehmainen, Marjukka https://orcid.org/0000-0002-3770-2538
- License Information
-
More Information
Article History
Received: 18 January 2024
Revised: 12 March 2025
Accepted: 27 March 2025
First Online: 10 April 2025
Competing interests
: M.O.A.S., R.V.U., V.I., C.G.G., H.N., J.L., and M.K. are co-inventors of a patent related to the therapeutic effects of the engineered strain in MASLD (WO2023208816). The University of Eastern Finland and the Technical University of Denmark are co-owners of this patent. The remaining authors declare no conflicts of interest.
